2026 NPPES data Colon & Rectal Surgery Physician NPI 1720139488 M.D.
Verify on CMS →

BETH MOORE, M.D.

Colon & Rectal Surgery Physician in WEST HOLLYWOOD, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
520
Medicare Part D claims · 340 beneficiaries · Colon & Rectal Surgery Physician avg: 196
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$219.51
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BETH MOORE, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 520 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
520
Part D claims, 2023
84%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BETH MOORE, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

BETH MOORE, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BETH MOORE, M.D.?

Below national average

NPI registry status

Active

Issued 01/16/2007

NPI 1720139488

Primary specialty

Colon & Rectal Surgery Physician

Niche

1,608 US NPIs in this specialty

Medicare Part D claims

520 165% vs specialty avg

2023 prescription claims

Specialty avg: 196

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in California

How Colon & Rectal Surgery Physician compares to other specialties among California providers

California providers

Colon & Rectal Surgery Physician share within California

1. Colon & Rectal Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Colon & Rectal Surgery Physician share within California

Medicare quality performance — MIPS

BETH MOORE, M.D.'s 2023 MIPS final score plotted against the Colon & Rectal Surgery Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Colon & Rectal Surgery Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Colon & Rectal Surgery Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BETH MOORE, M.D. appears in the CMS NPPES registry as a Colon & Rectal Surgery Physician provider holding M.D. credentials at 8737 BEVERLY BLVD STE 402, WEST HOLLYWOOD, CA, 90048, with a listed phone of (310) 854-3580. NPI 1720139488 was issued on 01/16/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MOORE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 520 prescription claims written by this provider, covering 340 Medicare beneficiaries and totaling roughly $59K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 2.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Colon & Rectal Surgery Physician is a narrow specialty nationwide, with 1,608 enrolled providers across 50 states and an average of 196 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8737 BEVERLY BLVD STE 402
WEST HOLLYWOOD, CA 90048

Provider Details

NPI 1720139488
Specialty Colon & Rectal Surgery Physician
Credentials M.D.
Gender Female
NPI Issued 01/16/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BETH MOORE, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$220

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to BETH MOORE, M.D.. To verify BETH MOORE, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

BETH MOORE, M.D. — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 520 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

520
Total Claims
$59K
Total Drug Cost
340
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
546
Total Day Supply
8,463
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$25K
Generic Drug Cost
$33K
Opioid Claims
11 (2.1% rate)
Antibiotic Claims
39

Patient Demographics

Average Patient Age
75.0 years
Avg HCC Risk Score
1.10
Gender Split
69% female / 31% male
Age Distribution
<65: 11, 65-74: 165, 75-84: 132, 85+: 32

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BETH MOORE, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Hydrocortisone
149
Procto-Med Hc
Hydrocortisone
57
Clenpiq
Sod Picosulf/Mag Ox/Citric Ac
52
Proctosol-Hc
Hydrocortisone
33
Mesalamine
17
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
16
Proctozone-Hc
Hydrocortisone
14
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
13
Gavilyte-G
"Peg3350/Sod Sulf
N/A
Sod Sulf-Potass Sulf-Mag Sulf
"Sodium
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Colon & Rectal Surgery Physician Overview

How BETH MOORE, M.D. fits within the Colon & Rectal Surgery Physician landscape nationally.

1,608
Colon & Rectal Surgery Physician Providers in US
50
States with Colon & Rectal Surgery Physician
196
Avg Claims per Provider

BETH MOORE, M.D.'s 520 claims are above the specialty average of 196.

Nearby Colon & Rectal Surgery Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as MOORE.

Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BETH MOORE, M.D.'s specialty?
BETH MOORE, M.D. specializes in Colon & Rectal Surgery Physician and practices in WEST HOLLYWOOD, California. Credentials: M.D..
How much does BETH MOORE, M.D. prescribe under Medicare Part D?
In 2023, BETH MOORE, M.D. wrote 520 Medicare Part D claims totaling $59K in drug costs for 340 beneficiaries.
What is BETH MOORE, M.D.'s Medicare quality score?
BETH MOORE, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BETH MOORE, M.D. located?
BETH MOORE, M.D. is located at 8737 BEVERLY BLVD STE 402, WEST HOLLYWOOD, CA, 90048. Phone: (310) 854-3580.
What is BETH MOORE, M.D.'s NPI number?
BETH MOORE, M.D.'s National Provider Identifier (NPI) is 1720139488, issued on 01/16/2007.
Does BETH MOORE, M.D. prescribe more brand-name or generic drugs?
BETH MOORE, M.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $25K in brand drug costs.
Does BETH MOORE, M.D. prescribe opioids?
Yes, BETH MOORE, M.D. had 11 opioid claims in 2023 with an opioid prescribing rate of 2.1%.
How many Colon & Rectal Surgery Physician providers are there in the US?
There are 1,608 Colon & Rectal Surgery Physician providers across 50 states in the US. The average Colon & Rectal Surgery Physician provider writes 196 Medicare Part D claims per year.
What drugs does BETH MOORE, M.D. prescribe most often?
Based on 2023 Medicare Part D data, BETH MOORE, M.D.'s most frequently prescribed drugs include Hydrocortisone, Procto-Med Hc, Clenpiq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BETH MOORE, M.D. accept Medicare?
BETH MOORE, M.D. appears in CMS Medicare data with 520 Part D claims and 340 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BETH MOORE, M.D.'s credentials?
BETH MOORE, M.D.'s NPI is 1720139488 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology